SPDE Speedus Corp. featured news, full reports, and detailed charts
Speedus Corp. (SPDE) Wrap Up:
Speedus Corp. is a holding company that owns significant equity interests in diverse businesses. We seek business opportunities across all industries for potential transactions and relationships in which we can apply our current resources and management strengths. The companies that we target, either public or privately held, will be seeking growth or restructuring capital to pursue near term business objectives in demonstrated markets. We will continue to pursue opportunities involving our expertise in the medical device and wireless markets, as well as those areas involving our broadband assets as attractive opportunities present themselves. We have co-invested with Siemens Corporate Research, Inc., a subsidiary of Siemens Corporation, in Zargis Medical Corp. to develop advanced diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists and other healthcare professionals. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f31%2f0001169232-08-001513.html#FIS_BUSINESS"www.speedus.com
20 Employees
Founded in 1995
Speedus Corp. (SPDE*(D):NASDAQ)
LAST $4.17 USD
CHANGE TODAY -0.0101 -0.24%
VOLUME 8.4K
*(D) = Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
As of 3:59 PM 11/20/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).
Snapshot of Speedus Corp. (SPDE)
|
OPEN
$4.27
|
PREVIOUS CLOSE
$4.18
|
|
|
DAY HIGH
$4.27
|
DAY LOW
$4.00
|
|
|
52 WEEK HIGH
09/17/09 - $8.83
|
52 WEEK LOW
03/12/09 - $0.27
|
|
|
MARKET CAP
16.4M
|
AVERAGE VOLUME 3 mo
19.5K
|
|
|
DILUTED EPS TTM
$-1.69
|
SHARES OUTSTANDING
3.9M
|
|
|
SPDE Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
SPDE Top Compensated Officers
Mr. Shant S. Hovnanian
Chairman, Chief Executive Officer and Preside...
Age: 50
Total Annual Compensation: $275.0K
Mr. John A. Kallassy
Chief Financial Officer, Chief Accounting Off...
Age: 45
Total Annual Compensation: $232.0K
Executives, Board Directors
Compensation as of Fiscal Year 2008.
Key developments for Speedus Corp. (SPDE)
Speedus In Compliance With NASDAQ's Marketplace Rule 5250
10/20/2009
Speedus Corp. announced that on October 13th, 2009, it filed its Form 10-K for the year ended December 31, 2008, its Form 10-Q for the period ended March 31, 2009, and its Form 10-Q for the period ended June 30, 2009. As a result of these filings, Company received a letter from NASDAQ indicating that Company is now compliant with NASDAQ's Marketplace Rule 5250(c)(1). Accordingly, this matter is now closed. In addition, the Company is making an announcement to comply with NASDAQ Marketplace Rule 4350(b)(1)(B) which requires separate disclosure of receipt of an audit opinion containing a going concern emphasis. This announcement does not represent any change or amendment to the Company's financial statements or to its Annual Report on Form 10-K for the year ended December 31, 2008. The consolidated financial statements of the Company do not include any adjustments related to the going concern opinion and have been prepared under the assumption that the Company will continue as a going concern. As a result of the abovementioned filings, Company received notification on October 14, 2009 that NASDAQ Capital Market requires that Company comply with the NASDAQ Listing Rule 5550 which includes requirements that Company have either a minimum $2.5 million in stockholders' equity, a $35 million market capitalization or $500,000 of net income from continuing operations for the most recently completed fiscal year or two of the three most recently completed fiscal years. Company will submit a plan to regain compliance with this rule by October 29, 2009. If the plan is accepted by NASDAQ, NASDAQ has the authority to allow up to 105 days from October 14, 2009, the date of the original notification, for Company to regain compliance.
Speedus Corp. Reports Earnings Results for the Year Ended December 31, 2008
10/19/2009
Speedus Corp. reported earnings results for the year ended December 31, 2008. For the period, the company reported net loss of $9.2 million, down from $4.42 million for the previous fiscal year. Earnings per share were $2.31, down from $1.11 for the previous fiscal year.
Speedus Corp. Auditor Raises 'Going Concern' Doubt
10/13/2009
Speedus Corp. filed its 10-K on October 13, 2009 for the period ending December 31, 2008. In this report its auditor, Amper, Politziner & Mattia, P.C., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
SPDE Competitors
| Company | Last | Change |
| MSTI Holdings Inc | $0.03 USD | 0.00 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | SPDE | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 154.5x |
|
| Price/Book | 34.4x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 108.1x |
|
|
SPDE |
||
|
SPDE transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About Speedus Corp.
More news for SPDE
SPEEDUS CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
Show all filings for SPEEDUS CORP | Request a Trial to NEW EDGAR Online Pro Form 8-K for SPEEDUS CORP 21-Oct-2009Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provide...Click here to read the whole Article (external link)
Midday Movers: Pump Up the Volume
Stock quotes in this article: SPDE , CHIP , BQI , ...Click here to read the whole Article (external link)
Zargis Cleared as Apple iPhone Developer; Medical Applications for Smartphones Planned
STAMFORD, Conn., Oct. 21 /PRNewswire/ -- Zargis Medical Corp., a subsidiary of Speedus Corp. (Nasdaq: SPDE - News) and a spin-off from Siemens Corporate Research (NYSE: SI - News), today announced that is has been cleared as an Apple(®) iPhone(®) developer and has begun development of medical diagnostic support software and related peripherals for the iPhone and other leading smartphones. Zargis has identified the handheld environment as a logical delivery platform for its telemedicine and diagnostic software initiatives, and with its team of experienced developer's plans to leverage the smartphone platform as a mobile hub between medical device peripherals and computer-aided diagnostic support located either locally or remotely.A recent report released by Manhattan Research stated that 64% of doctors, more than double the number eight years ago, own smartphones, and that this figure will increase to 81% penetration in 2012. However, despite the rapid adoption of the iPhone and other smartphones by physicians, currently available healthcare applications for these devices are generally limited to medical reference libraries, educational tools and applications designed to manage patient medical records....Click here to read the whole Article (external link)
Speedus Corp. Names Stephen X. Graham to Board of Directors
FREEHOLD, N.J., Nov. 11 /PRNewswire-FirstCall/ -- Speedus Corp. (Nasdaq: SPDE - News) today announced that on November 11, 2009 Stephen X. Graham was appointed to the Company's Board of Directors. Mr. Graham is Managing Director of Crosshill Financial Group, Inc., which he founded in 1988, and has been a General Partner of Crosshill Georgetown Capital, L.P. since November 2000 and Crosshill Debt II, L.P. since 2004. Prior to these roles Mr. Graham was a Principal with Kidder Peabody & Co. and held positions with Merrill, Lynch & Co. and Arthur Young & Co. Mr. Graham received a B.A. from Georgetown University and an MBA from the University of Chicago Graduate School of Business. He is also a board member of NYSE-traded TNS Inc. and several private companies.In view of his extensive financial experience, the Company's Board has invited Mr. Graham to serve on the audit committee of the Board of Directors, and the Board anticipates that he will be invited to serve on other committees as well."We are proud to have Stephen join our Board of Directors. We look forward to his insight as our company continues to develop our exciting technologies," stated Shant Hovnanian, Speedus' chairman, president and CEO."About Speedus Corp.Additional information on Speedus Corp. may be obtained at www.speedus.com...Click here to read the whole Article (external link)
Density Dynamics Launches Upgrade Incentive Program for Legacy TiGiJet SSDs; Over 60 Prior Customers Qualify Including Lockheed Martin and Wachovia
GERMANTOWN, Md., Nov. 5 /PRNewswire/ -- Density Dynamics, a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE - News), announced today it has launched an incentive program for customers who purchased the company's legacy TiGiJet Solid State Drives to upgrade to its next generation Jet.io Solid State Drives. Under the program, customers may trade-in their existing TiGiJet SSDs and receive a 50% trade in credit from the original purchase price for each TiGiJet unit traded in towards a new Jet.io(TM) SSD. Without trade-in, prior customers will be given a 30% purchase voucher for any new production units ordered prior to January 2010. This program begins immediately. To take advantage of this offer, all orders must be received by January 29, 2010. "When we purchased the assets of TiGi Corp in March of 2008, we immediately commenced work on the enhanced Jet.io product which extends the legacy of high performance and durability from the TiGiJet product into higher density designs and a low-profile Fibre Channel drive format. Like the TiGiJet product, the Jet.io utilizes DRAM core storage as a key differentiator from the fla...Click here to read the whole Article (external link)
3M Health Care and Zargis Medical Awarded "Innovation of the Year" for Littmann® Model 3200 Stethoscope with Cardioscan Software
ST. PAUL, Minn. & STAMFORD, Conn.--(BUSINESS WIRE)--3M Health Care and Zargis Medical, a majority-owned subsidiary of Speedus Corp. (Nasdaq:SPDE - News), announced today that the 3M™®™Popular Science’s “Innovation of the Year.†This prestigious honor, part of the publication’s annual “Best of What’s New Awards,†highlights outstanding innovation, vision and execution in technologic, scientific and medical advances for the year. “Pairing the Littmann Electronic Stethoscope Model 3200 with Zargis Cardioscan software is a gigantic step forward in changing the way clinicians listen to and interpret heart sounds,†said Debra Rectenwald, vice president and general manager, 3M Infection Prevention division. “This award is a testament to the spirit that drives 3M’s innovation to develop and create new ways to improve the delivery of healthcare.â€â€œTogether, 3M and Zargis took the basic electronic stethoscope and transformed it into an advanced clinical tool that can improve diagnostic capabilities,†said John Kallassy, chief executive officer of Zargis Medical. “Cardioscan is a breakthrough in medical technology that has the potential to reduce unnecessary medical referrals while improving outcomes at the same time.â€â„¢ software for analysis. The stethoscope and Cardioscan ...Click here to read the whole Article (external link)
SPEEDUS CORP Files SEC form 8-K, Change in Directors or Principal Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 11, 2009, Stephen X. Graham was appointed by action of our Board of Directors to serve on the Board of Speedus Corp. commencing immediately and continuing through the current term. In addition, the Speedus management has determined to nominate Mr. Graham for election as a director of Speedus Corp. at the next annual meeting scheduled to be held on December 17, 2009. Mr. Graham is Managing Director of Crosshill Financial Group, Inc., which he founded in 1988, and has been a General Partner of Crosshill Georgetown Capital, L.P. since November 2000 and Crosshill Debt II, L.P. since 2004. Prior to these roles, Mr. Graham was a Principal with Kidder Peabody & Co. and held positions with Merrill, Lynch & Co. and Arthur Young & Co. Mr. Graham received a B.A. from Georgetown University and an MBA from the University of Chicago Graduate School of Business. He is also a board member of TNS Inc. (NYSE: TNS) and several private companies. Mr. Graham currently serves as a director of Density Dynamics Corporation, our majority-owned subsidiary. Crosshill Georgetown Capital, LP, for which Mr. Graham serves as a General Partner, was one of the founder shareholders of Density Dynamics and also owns a minority equity interest in that company. As a result of this prior experience, although Mr. Graham will qualify as an independent director of Speedus Corp., he comes with deep understanding of much of our business activities. In view of his extensive financial experience, Mr. Graham has been appointed to serve on the audit committee of Speedus' Board of Directors, and the Board anticipates that he will be invited to serve on other committees as well. As a result of Mr. Graham's appointment, the Company has regained compliance with the independent director and audit committee requirements as set forth in Nas...Click here to read the whole Article (external link)
SPEEDUS CORP Files SEC form 10-Q, Quarterly Report
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis of financial condition and results of operations should be read in conjunction with the corresponding discussion and analysis included in the Company's Report on Form 10-K for the year ended December 31, 2008. Cautionary Statement Regarding Forward-Looking Information This Management's Discussion and Analysis of Financial Condition and Results of Operations and other sections of this Form 10-Q contain "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements appear in a number of places in this Form 10-Q and include statements regarding the intent, belief or current expectations of the Company or its officers with respect to, among other things, the ability of the Company to make capital expenditures, the ability to incur additional debt, as necessary, to service and repay such debt, if any, as well as other factors that may effect the Company's financial condition or results of operations. Forward-looking statements may include, but are not limited to, projections of revenues, income or losses, capital expenditures, plans for future operations, financing needs or plans, compliance with covenants in loan agreements, plans for liquidation or sale of assets or businesses, plans relating to products or services of the Company, assessments of materiality, predictions of future events, and the ability to obtain additional financing, including the Company's ability to meet obligations as they become due, and other pending and possible litigation, as well as assumptions relating to the foregoing. All statements in this Form 10-Q regarding industry prospects and the Company's financial position are forward-looking statements. Readers are cautioned not to place undue reliance on these forward-lo...Click here to read the whole Article (external link)
Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference
STAMFORD, Conn., Nov. 13 /PRNewswire-FirstCall/ -- Speedus Corp. (Nasdaq: SPDE - News) today announced that it will be releasing a free trial version of its Zargis Cardioscan software during the American Heart Association's 2009 Scientific Sessions conference, taking place this November 15-17 in Orlando. Zargis is exhibiting at the conference with 3M Littmann, the developers of the companion hardware -- the 3M Littmann Electronic Stethoscope Model 3200 -- which wirelessly transfers heart, lung and other body sounds to Zargis Cardioscan and Zargis StethAssist software for further analysis. Popular Science magazine. This free trial version was created to allow healthcare professionals to experience the benefits of Cardioscan's diagnostic support features as well as Zargis' accompanying tele-auscultation system.The annual American Heart Association's Scientific Sessions conference is the world's pre-eminent gathering of healthcare professionals devoted to understanding, treating, assessing, and preventing cardiovascular disease and stroke. The 2008 Scientific Sessions event was attended by more than 17,000 medical professionals.About Zargis Medical Corp.Zargis Medical Corp. develops advanced diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists and other healthcare professionals. Zargis was formed in 2001 when Siemens Corporate Research, a division of Siemens AG (NYSE: ...Click here to read the whole Article (external link)
Would you like to leave a comment about Speedus Corp. SPDE
Find out what social network information about Speedus Corp. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Speedus Corp. there is more great information available at Realpennies.com